Improving Cancer Detection with Biomarkers
Biomarker Reference Laboratory
This lab helps find and confirm important biological markers to improve how we detect and manage cancer, especially prostate cancer.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project ID | NIH-11111412 on NIH RePORTER |
What this research studies
Our lab at Johns Hopkins works to confirm new biological markers, called biomarkers, that can help doctors understand and treat cancer. We focus on developing accurate tests for prostate cancer, aiming to predict how aggressive the cancer is before surgery. This work also seeks to identify non-invasive markers to detect signs of cancer progression during active surveillance, helping patients decide if further treatment is needed. We use advanced technologies and follow strict quality guidelines to ensure reliable results for future diagnostic tools.
Who could benefit from this research
Good fit: Patients with prostate cancer, particularly those considering active surveillance or needing better assessment of their cancer's aggressiveness, could eventually benefit from this research.
Not a fit: Patients without prostate cancer or those whose cancer is already well-characterized by existing methods may not directly benefit from this specific biomarker validation work.
Why it matters
Potential benefit: If successful, this work could lead to more accurate and less invasive ways to diagnose prostate cancer and monitor its progression, helping patients make better treatment decisions.
How similar studies have performed: The general approach of using biomarkers for cancer diagnostics has shown promise in other areas, and this work builds on existing discoveries.
Where this research is happening
Baltimore, United States
- Johns Hopkins University — Baltimore, United States (Active)
Researchers
- Principal investigator: Chan, Daniel Wanyui — Johns Hopkins University
- Study coordinator: Chan, Daniel Wanyui
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.